Fetuin-A, a Promising Serum Biomarker for Diagnosis of Non-Alcoholic Fatty Liver Disease
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:October 25, 2023Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:October 25, 2023Enrolling by invitation
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:August 27, 2018Unknown status
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:June 29, 2022Recruiting
Condition(s):NAFLD- Non Alcoholic Fatty Liver DiseaseLast Updated:May 3, 2022Recruiting
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:August 20, 2020Completed
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:August 8, 2019Completed
Condition(s):Non-alcoholic Fatty Liver Disease (NAFLD)Last Updated:March 30, 2017Withdrawn
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:November 14, 2023Suspended
Condition(s):Non-alcoholic Fatty Liver DiseaseLast Updated:October 11, 2018Completed
Condition(s):Non-alcoholic Fatty Liver Disease; Nonalcoholic SteatohepatitisLast Updated:October 17, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.